Source link : https://newshealth.biz/health-news/fda-approves-prostate-cancer-combo-that-warranted-advisory-meeting/
The FDA approved capivasertib (Truqap) in combination with abiraterone (Zytiga) and prednisone for PTEN-deficient prostate cancer, the agency announced on Friday. Approval stipulates use in metastatic hormone-sensitive prostate cancer — or what is now pithily being called metastatic androgen pathway modulation-naive or -sensitive prostate cancer. In the phase III CAPItello-281 trial, adding capivasertib to abiraterone […]
The post FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-12 21:10:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8